Iambic Therapeutics, Inc. (IAM) has 1 open-market insider trade by 1 insider since 2026. Over the last six months insiders net bought $11.5M. The most active filer is Evan Lockwood Rachlin, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Evan Lockwood Rachlin | Dir | — | 1 | $11.5M | 2026-10-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Evan Lockwood Rachlin | Director | Buy | $11.5M | 2026-10-16 |
Companies that share insiders with IAM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.